Literature DB >> 26072701

Interventional Radiologist's perspective on the management of bone metastatic disease.

R L Cazzato1, X Buy2, R F Grasso3, G Luppi4, E Faiella5, C C Quattrocchi6, F Pantano7, B Beomonte Zobel8, G Tonini9, D Santini10, J Palussiere11.   

Abstract

Bone metastases can be treated by interventional radiologists with a minimally invasive approach. Such treatments are performed percutaneously under radiological imaging guidance. Different interventional techniques can be applied with curative or palliative intent depending on lesions and patients' status. In the whole, available interventional techniques are distinguished into "ablative" and "consolidative". Ablative techniques achieve bone tumor necrosis by dramatically increasing or decreasing intra-tumoral temperature. This option can be performed in order to alleviate pain or to eradicate the lesion. On the other hand, consolidative techniques aim at obtaining bone defect reinforcement mainly to alleviate pain and prevent pathological fractures. We herein present evidence supporting the application of each different interventional technique, as well as common strategies followed by interventional radiologists while approaching bone metastases.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ablation; Bone; Cementoplasty; Interventional radiology; Metastasis

Mesh:

Year:  2015        PMID: 26072701     DOI: 10.1016/j.ejso.2015.05.010

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

Review 1.  Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer.

Authors:  Roberto Luigi Cazzato; Julien Garnon; Guillaume Koch; Behnam Shaygi; Georgia Tsoumakidou; Jean Caudrelier; Emanuele Boatta; Xavier Buy; Jean Palussiere; Afshin Gangi
Journal:  Gland Surg       Date:  2018-04

Review 2.  Interventional Techniques for the Ablation and Augmentation of Extraspinal Lytic Bone Metastases.

Authors:  Osman Ahmed; Nicholas Feinberg; William B Lea
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

Review 3.  Interventional Palliation of Painful Extraspinal Musculoskeletal Metastases.

Authors:  Anderanik Tomasian; Jack W Jennings
Journal:  Semin Intervent Radiol       Date:  2022-06-30       Impact factor: 1.780

Review 4.  Minimally Invasive Interventional Procedures for Metastatic Bone Disease: A Comprehensive Review.

Authors:  Nicolas Papalexis; Anna Parmeggiani; Giuliano Peta; Paolo Spinnato; Marco Miceli; Giancarlo Facchini
Journal:  Curr Oncol       Date:  2022-06-07       Impact factor: 3.109

5.  The minimally invasive endoscopic technique for the treatment of symptomatic benign bone lesions: Preliminary results from a retrospective study.

Authors:  Min-Hao Wu; Ling-Fei Xiao; Chong Zhang; Jun Lei; Zhou-Ming Deng
Journal:  J Bone Oncol       Date:  2020-08-02       Impact factor: 4.072

Review 6.  Developments in the management of bone metastases with interventional radiology.

Authors:  Francesco Arrigoni; Federico Bruno; Luigi Zugaro; Raffaele Natella; Salvatore Cappabianca; Umberto Russo; Vito Roberto Papapietro; Alessandra Splendiani; Ernesto Di Cesare; Carlo Masciocchi; Antonio Barile
Journal:  Acta Biomed       Date:  2018-01-19

Review 7.  Percutaneous consolidation of bone metastases: strategies and techniques.

Authors:  Roberto Luigi Cazzato; Julien Garnon; Benham Shaygi; Emanuele Boatta; Guillaume Koch; Jean Palussiere; Xavier Buy; Afshin Gangi
Journal:  Insights Imaging       Date:  2019-02-06

Review 8.  Bone metastases in thyroid cancer.

Authors:  Nicole M Iñiguez-Ariza; Keith C Bible; Bart L Clarke
Journal:  J Bone Oncol       Date:  2020-02-19       Impact factor: 4.072

9.  Evaluation of short-term efficacy of extraspinal cementoplasty for bone metastasis: A monocenter study of 31 patients.

Authors:  Gaëlle Couraud; Gaston André-Pierre; Tulier Titien; Eymard Florent; Hourdille Alexia; Chevalier Xavier-Jean; Hélene Boussion; Guignard Sandra
Journal:  J Bone Oncol       Date:  2018-09-19       Impact factor: 4.072

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.